| Product NDC: | 0781-1393 |
| Proprietary Name: | Haloperidol |
| Non Proprietary Name: | Haloperidol |
| Active Ingredient(s): | 2 mg/1 & nbsp; Haloperidol |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 0781-1393 |
| Labeler Name: | Sandoz Inc |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA071208 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 19861117 |
| Package NDC: | 0781-1393-10 |
| Package Description: | 1000 TABLET in 1 BOTTLE (0781-1393-10) |
| NDC Code | 0781-1393-10 |
| Proprietary Name | Haloperidol |
| Package Description | 1000 TABLET in 1 BOTTLE (0781-1393-10) |
| Product NDC | 0781-1393 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Haloperidol |
| Dosage Form Name | TABLET |
| Route Name | ORAL |
| Start Marketing Date | 19861117 |
| Marketing Category Name | ANDA |
| Labeler Name | Sandoz Inc |
| Substance Name | HALOPERIDOL |
| Strength Number | 2 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Typical Antipsychotic [EPC] |